BIPAGEN

Bioprospecting, Pathogens and Genetic Models


About the Project

EMU Biological Collections Infrastructure: Acquisition of a Multi-User Platform for Microbiological Collections aimed at Bioprospecting, Pathogens and Genetic Models (BIPAGEN) is a project that proposes the creation of a multi-user platform for the storage, characterization, exchange, and safe use of microbiological collections encompassing microorganisms of interest in bioprospecting, clinical and veterinary pathogens, and genetic models for basic research.

The platform integrates high-standard physical infrastructure for microbial preservation, digital collection management systems, and biosafety protocols, serving as a national hub for academic collaboration and technology transfer. Brazil holds one of the largest microbial biodiversities on the planet, still under-explored. Many strains with potential for antibiotics, enzymes, biopolymers, or pharmaceutical and agricultural compounds remain restricted to isolated labs without unified management or structured sharing.

Coordinator

Dr. Gustavo H. Goldman, PhD
FCFRP-USP

Associated Researchers

  • Norberto Peporine Lopes, FCFRP-USP
  • Mônica T. Pupo, FCFRP-USP
  • Germán Gustavo Sgro, FCFRP-USP
  • Ricardo Roberto da Silva, FCFRP-USP

Infrastructure & Equipment

  • Eppendorf epMotion 5075t NGS solution robot — liquid handling and inoculation in 96/384-well plates
  • Laminar flow hood — sterile handling of samples
  • Two -80°C freezers — long-term microbial preservation
  • Liquid nitrogen tanks (-196°C) — cryopreservation of high-value strains
  • Lyophilizers — freeze-drying for stable, ambient-temperature storage
  • LIMS platform — digital management with metadata tracking (geographic origin, molecular characterization, legal compliance)

Services & Pricing

The BIPAGEN collection offers strains in four categories. Prices are per strain and include a basic technical datasheet.

Category Description Examples Public Universities Private Sector
1 — Basic Strains Common, non-pathogenic, easy to cultivate. E. coli K-12, Bacillus subtilis 168, wild-type Saccharomyces cerevisiae. R$ 200,00 R$ 400,00
2 — Standard Strains Non-pathogenic bacteria, yeasts, and filamentous fungi with specific characteristics. Pseudomonas putida, Lactobacillus spp., Aspergillus niger (non-toxigenic). R$ 300,00 R$ 600,00
3 — Specialized Strains Biosafety Level 2 (BSL-2) pathogens, fastidious microorganisms, or strains with common vectors/plasmids. Staphylococcus aureus (ATCC 25923), Salmonella enterica, E. coli BL21(DE3) + pET plasmid. R$ 500,00 R$ 1.000,00
4 — Premium Strains Patented strains, high commercial value, complex genetic constructs, or BSL-3 pathogens (with specific legal restrictions). Patented enzyme/antibody-producing strains, Mycobacterium tuberculosis (BSL-3), specific knockout strains. R$ 600,00 – R$ 1.500,00 R$ 1.200,00 – R$ 3.000,00
Important Notes
  • Documentation: All prices include a basic technical datasheet. Certificate of Analysis (viability, purity, confirmatory molecular test) incurs an additional fee.
  • Licenses: Patented strains are subject to Material Transfer Agreements (MTA) and may require additional licensing fees not included in the listed price.
  • Shipping: Not included. Shipping costs (special packaging with dry ice or recyclable ice) are calculated separately and borne by the buyer.

Main Goals

  1. Establish physical infrastructure for long-term microbial conservation (-80°C, lyophilization, cryopreservation).
  2. Create a computerized system for strain registration, traceability, and access.
  3. Implement biosafety protocols with BSL-1 and BSL-2 containment levels.
  4. Develop a database interconnected with national and international collection networks.
  5. Train users in safe handling and legal documentation of microbial resources.
  6. Promote open access for the scientific community and companies with a transparent usage policy.

Registered Collections

Our collection is registered at: SiBBr and SpeciesLink (CRIA).

Technical Team: Dra. Marcela Savoldi (PhD in Genetics, FMRP-USP) and Livia Alfaya (MSc, FMRP-USP).